We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$318B
AUM Growth
+$7.42B
Cap. Flow
+$12.8B
Cap. Flow %
4.02%
Top 10 Hldgs %
13.83%
Holding
10,865
New
1,329
Increased
3,996
Reduced
3,899
Closed
1,129

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$541M
2
MSFT icon
Microsoft
MSFT
+$517M
3
META icon
Meta Platforms (Facebook)
META
+$493M
4
WTW icon
Willis Towers Watson
WTW
+$405M
5
AMZN icon
Amazon
AMZN
+$372M

Sector Composition

Rank Sector Weight
1 Technology 12.18%
2 Financials 7.26%
3 Consumer Discretionary 6.08%
4 Healthcare 6.04%
5 Communication Services 4.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MEXX icon
5976
Direxion Daily MSCI Mexico Bull 3X ETF
MEXX
$20.3M
$81K ﹤0.01%
4,845
+2,735
+130% +$48.3K
STR
5977
DELISTED
Sitio Royalties
STR
$81K ﹤0.01%
4,283
-4,282
-50% -$79.9K
SUPN icon
5978
Supernus Pharmaceuticals
SUPN
$2.77B
$81K ﹤0.01%
3,048
-21,095
-87% -$566K
UL icon
5979
PUT
Unilever
UL
$136B
$81K ﹤0.01%
1,333
-178
-12% -$11.3K
USXF icon
5980
iShares ESG Advanced MSCI USA ETF
USXF
$1.49B
$81K ﹤0.01%
2,251
+772
+52% +$28.7K
ADAP
5981
DELISTED
Adaptimmune Therapeutics
ADAP
$80K ﹤0.01%
15,505
+1,593
+11% +$7.15K
FGM icon
5982
First Trust Germany AlphaDEX Fund
FGM
$99.1M
$80K ﹤0.01%
1,458
+17
+1% +$977
GREK
5983
Global X MSCI Greece ETF
GREK
$316M
$80K ﹤0.01%
2,948
+74
+3% +$2.06K
MCK icon
5984
PUT
McKesson
MCK
$101B
$80K ﹤0.01%
400
+200
+100% +$40K
QUBT icon
5985
Quantum Computing Inc
QUBT
$2.07B
$80K ﹤0.01%
+12,783
New +$93.4K
RNEM icon
5986
First Trust Emerging Markets Equity Select ETF
RNEM
$17.2M
$80K ﹤0.01%
1,666
+299
+22% +$14.8K
SEVN
5987
Seven Hills Realty Trust
SEVN
$174M
$80K ﹤0.01%
7,801
-1,469
-16% -$16.4K
ENG
5988
DELISTED
ENGlobal Corp
ENG
$80K ﹤0.01%
3,750
-137
-4% -$2.55K
GERM
5989
DELISTED
Amplify Treatments, Testing and Advancements ETF
GERM
$80K ﹤0.01%
1,949
+1,437
+281% +$60.6K
IMPL
5990
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$80K ﹤0.01%
6,531
+5,361
+458% +$77.8K
MACC.U
5991
DELISTED
Mission Advancement Corp. Units, each consisting of one share of Class A Common Stock and one-third of one Redeemable Warrant
MACC.U
$80K ﹤0.01%
8,080
-2,513
-24% -$24.9K
CYXTW
5992
DELISTED
Cyxtera Technologies, Inc. Warrant
CYXTW
$80K ﹤0.01%
38,507
+33,808
+719% +$65.8K
ATER icon
5993
Aterian
ATER
$5.37M
$79K ﹤0.01%
605
-23
-4% -$2.55K
COLL icon
5994
Collegium Pharmaceutical
COLL
$956M
$79K ﹤0.01%
4,045
-11,846
-75% -$256K
ISRA icon
5995
VanEck Israel ETF
ISRA
$159M
$79K ﹤0.01%
1,661
+375
+29% +$17.8K
MRBK icon
5996
Meridian
MRBK
$234M
$79K ﹤0.01%
5,500
-2,348
-30% -$31.8K
PHI icon
5997
PLDT
PHI
$4.33B
$79K ﹤0.01%
2,433
+260
+12% +$7.05K
VIVO
5998
VivoPower PLC
VIVO
$124M
$79K ﹤0.01%
1,397
+97
+7% +$5.91K
WRLD icon
5999
World Acceptance Corp
WRLD
$873M
$79K ﹤0.01%
417
-471
-53% -$87K
HYB
6000
DELISTED
New America High Income Fund, Inc.
HYB
$79K ﹤0.01%
8,222
-466
-5% -$4.38K

Similar funds

UBS Group's Q3 2021 Portfolio in Review

As of Q3 2021, UBS Group held 10,865 positions worth $318B, up 2.4% from $310B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $12.8B of net new capital in Q3 2021, opening 1,329 new positions and adding to 3,996 existing holdings. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 1,947,829 shares worth $50.4M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $626M trimmed.

  • UBS Group's largest Q3 2021 buy was Dimensional World ex US Core Equity 2 ETF: 1,947,829 shares worth $50.4M.
  • UBS Group added most to Apple in Q3 2021, an estimated $541M increase.
  • UBS Group's biggest Q3 2021 reduction was Invesco QQQ Trust, cutting an estimated $626M.
  • UBS Group fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $282M.
  • UBS Group's ten largest holdings make up 14% of its $318B portfolio in Q3 2021.
  • UBS Group opened 1,329 new positions and closed 1,129 in Q3 2021.
  • UBS Group's portfolio value rose 2.4% quarter-over-quarter to $318B.

Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.